Stock screenerAll disclosures →
EDGAR →
PLRX
Conviction 14HealthcareScan · Thu, Jun 25, 2026PLRX$1.12-0.88%
ResistanceSupportVol 14Vol MA14 387.14K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.12
Change-0.88%
Gap+0.88%
Rel volume1.68×
Avg volume479.94K
Avg $ vol560.48K
SMA 201.17
SMA 501.20
SMA 2001.35
Price vs 50-6.89%
Price vs 200-16.92%
MA stackbearish
50/200 cross—
Supertrenddown · 1.27
RSI (14)39
MACD hist-0.00
MACD crossbear · 1d
Stoch %K / %D11 / 22
ADX (14)14
+DI / −DI13 / 22
RSI divergence—
MACD divergence—
ATR %+4.28%
ADR %4.10%
52w high1.87
52w low1.09
From 52w high-40.11%
Above 52w low+2.75%
New 52w highNo
SqueezeOn · 1d
Bollinger width12.14%
%B0.15
Donchian pos6.06%
Donchian high1.28
Donchian low1.11
AVWAP (52w high)1.32
vs AVWAP high-15.28%
AVWAP (52w low)1.24
vs AVWAP low-9.34%
OBV trendDown
Chaikin MF (20)-0.23
Today vs 20d1.68×
Avg vol (14d)387.14K
Avg vol (20d)479.94K
Avg $ vol (20d)560.48K
Market cap69.35M
RS 3m (vs SPY)-23.98%
RS 6m (vs SPY)-15.87%
RS line new highNo
Trend template0/8
Technical rank21.5
1 week-5.08%
1 month-9.68%
3 months-14.50%
6 months-9.68%
1 year-13.85%
YTD-10.40%
P/E-0.46
P/B0.42
P/S—
P/FCF-0.54
EPS-2.43
Div yield—
ROE-90.42%
ROA-73.72%
Debt/Eq0.00
Current16.89
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth28.99%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value47.16M
Revenue0
Net income-20.04M
Gross profit—
Free cash flow-128.71M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out61.92M
Employees49
ListedWed, Jun 3, 2020
Free float48.35M
Float %78.7%
Short interest3.44M
Days to cover6.0d
Short volume47.2%
Squeeze score54 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.33 · 3 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction14 / 100
Pattern quality—
Tech rank21.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.27
Support1.13
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PLRX
No recent disclosed trades by Congress in PLRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PLRX · 5 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Coulie Bernard President and CEO · Stock Option (Right to Buy) · 2026-04-17 | Grant | 325K | $0 | 2026-04-17 | 2026-04-17 |
Coulie Bernard President and CEO · Stock Option (Right to Buy) · 2026-04-17 | Disposition | 440K | $0 | 2026-04-17 | 2026-04-17 |
Kuo Minnie Chief Operating Officer · Stock Option (Right to Buy) · 2026-04-17 | Disposition | 40K | $0 | 2026-04-17 | 2026-04-17 |
Coulie Bernard President and CEO · Stock Option (Right to Buy) · 2026-04-17 | Disposition | 256.3K | $0 | 2026-04-17 | 2026-04-17 |
Coulie Bernard President and CEO · Stock Option (Right to Buy) · 2026-04-17 | Disposition | 250K | $0 | 2026-04-17 | 2026-04-17 |
Cummings Keith Lamont Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-17 | Disposition | 18.2K | $0 | 2026-04-17 | 2026-04-17 |
Cheung Lily Chief Human Resource Officer · Stock Option (Right to Buy) · 2026-04-17 | Grant | 51.75K | $0 | 2026-04-17 | 2026-04-17 |
Coulie Bernard President and CEO · Stock Option (Right to Buy) · 2026-04-17 | Grant | 206.3K | $0 | 2026-04-17 | 2026-04-17 |
Cummings Keith Lamont Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-17 | Grant | 76.2K | $0 | 2026-04-17 | 2026-04-17 |
Cummings Keith Lamont Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-17 | Grant | 74.25K | $0 | 2026-04-17 | 2026-04-17 |
SEC filings
EDGAR filings in PLRX · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.